Research and Markets: Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015
June 22 2015 - 10:31AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/x4qjj7/recurrent_head)
has announced the addition of the "Recurrent Head And Neck Cancer
Squamous Cell Carcinoma - Pipeline Review, H1 2015" report to their
offering.
This report provides comprehensive information on the
therapeutic development for Recurrent Head And Neck Cancer Squamous
Cell Carcinoma, complete with comparative analysis at various
stages, therapeutics assessment by drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type, along with
latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for
Recurrent Head And Neck Cancer Squamous Cell Carcinoma and special
features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to
create effective counter strategies to gain competitive advantage.
It strengthens R&D pipelines by identifying new targets and
MOAs to produce first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
- Advaxis, Inc.
- Amgen Inc.
- AVEO Pharmaceuticals, Inc.
- Critical Outcome Technologies Inc.
- Daiichi Sankyo Company, Limited
- Genentech, Inc.
- Glycotope GmbH
- Immunovative Therapies, Ltd.
- Laboratoires Pierre Fabre SA
- Mabion SA
- MedImmune, LLC
- Merck & Co., Inc.
- Novartis AG
- Oncolytics Biotech Inc.
- Ono Pharmaceutical Co., Ltd.
- Panacea Biotec Limited
- PCI Biotech AS
- Shionogi & Co., Ltd.
- Symphogen A/S
- VentiRx Pharmaceuticals, Inc.
For more information visit
http://www.researchandmarkets.com/research/x4qjj7/recurrent_head
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150622005987/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Oncology